Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival
复制标题
DOI:
10.1086/500468
复制
发表时间:
2006-03-15
影响因子:
6.4
通讯作者:
Eichacker, PQ
中科院分区:
文献类型:
--
作者:
Cui, XZ;Li, Y;Eichacker, PQ
Background. On the basis of the findings of previous in vitro studies, we hypothesized that anthrax lethal toxin (LeTx) would have anti-inflammatory effects in vivo.Methods. We investigated the effects of sublethal doses of LeTx in rats receiving intravascular challenge with lipopolysaccharide (LPS) or intratracheal challenge with Escherichia coli.Results. In rats receiving 24-h infusions of LPS, compared with control rats, pretreatment with high or low sublethal doses of LeTx 3 h before infusion produced similar patterns of reduction in the hazards ratio (HR) of survival at 168 h (0.60 [95% confidence interval {CI}, 0.37-0.98];, for the doses combined). LeTx increased mean arterial blood pressure throughout the period of LPS infusion (P = .001); decreased the levels of 10 of 13 cytokines assessed (i.e., interleukin [IL]-1 alpha, IL-1 beta, IL-2, IL-4, IL-6, IL-10, interferon-gamma, tumor necrosis factor-alpha, granulocyte macrophage-colony-stimulating factor, migratory inhibitory protein [MIP]-1 alpha, MIP-2, MIP-3 alpha, and RANTES) at 2 h; decreased all 13 cytokine levels at 8 h; decreased only 4 cytokine levels at 24 h; and decreased the plasma level of nitric oxide (NO) at 8 h and 24 h but not at 2 h (P